Trans-10, cis-12 conjugated linoleic acid inhibits skeletal muscle differentiation and GLUT4 expression independently from NF-κB activation

Molecular Nutrition and Food Research

Volumn 54, Issue 12, 2010, Pages 1763-1772

  Hommelberg, Pascal P H ^a,b   Plat, Jogchum ^a   Remels, Alexander H V ^a   Van Essen, Anon L M ^a   Kelders, Marco C J M ^a   Mensink, Ronald P ^a,b   Schols, Annemie M W J ^a   Langen, Ramon C J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

Author keywords

Glucose transporter 4; Myotube; Nuclear factor kappa B; Skeletal muscle differentiation; Trans 10, cis 12 conjugated linoleic acid

Indexed keywords

CONJUGATED LINOLEIC ACID; GLUCOSE TRANSPORTER 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOSIN HEAVY CHAIN; SLC2A4 PROTEIN, MOUSE; TRANS 10,CIS 12 CONJUGATED LINOLEIC ACID; TRANS-10,CIS-12-CONJUGATED LINOLEIC ACID;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; EVALUATION; GENE EXPRESSION REGULATION; GENETICS; INSULIN RESISTANCE; METABOLISM; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; RAT; SKELETAL MUSCLE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; INSULIN RESISTANCE; LINOLEIC ACIDS, CONJUGATED; MICE; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MYOBLASTS; MYOSIN HEAVY CHAINS; NF-KAPPA B; RATS;

EID: 78549266210     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000103     Document Type: Article

References (58)

1. Hawke, T. J., Garry, D. J., Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 2001, 91, 534-551.
2. Olson, E. N., Signal transduction pathways that regulate skeletal muscle gene expression. Mol. Endocrinol. 1993, 7, 1369-1378.
3. Mitsumoto, Y., Burdett, E., Grant, A., Klip, A., Differential expression of the GLUT1 and GLUT4 glucose transporters during differentiation of L6 muscle cells. Biochem. Biophys. Res. Commun. 1991, 175, 652-659.
4. Shimokawa, T., Kato, M., Ezaki, O., Hashimoto, S., Transcriptional regulation of muscle-specific genes during myoblast differentiation. Biochem. Biophys. Res. Commun. 1998, 246, 287-292.
5. Tsao, T. S., Burcelin, R., Katz, E. B., Huang, L., Charron, M. J., Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 1996, 45, 28-36.
6. Leturque, A., Loizeau, M., Vaulont, S., Salminen, M., Girard, J., Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes 1996, 45, 23-27.
7. Frosig, C., Rose, A. J., Treebak, J. T., Kiens, B. et al., Effects of endurance exercise training on insulin signaling in human skeletal muscle: interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160. Diabetes 2007, 56, 2093-2102.
8. Murgia, M., Jensen, T. E., Cusinato, M., Garcia, M. et al., Multiple signalling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscle. J. Physiol. 2009, 587, 4319-4327.
9. Langen, R. C., Schols, A. M., Kelders, M. C., Wouters, E. F., Janssen-Heininger, Y. M., Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J. 2001, 15, 1169-1180.
10. Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, C. Y., Baldwin, A. S., Jr., NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000, 289, 2363-2366.
11. Gilmore, T. D., The Rel/NF-kappaB signal transduction pathway: introduction. Oncogene 1999, 18, 6842-6844.
12. Pahl, H. L., Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18, 6853-6866.
13. Hommelberg, P. P., Plat, J., Langen, R. C., Schols, A. M., Mensink, R. P., Fatty acid-induced NF-κB activation and insulin resistance in skeletal muscle are chain length dependent. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E114-E120.
14. Jove, M., Planavila, A., Laguna, J. C., Vazquez-Carrera, M., Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells. Endocrinology 2005, 146, 3087-3095.
15. Jove, M., Planavila, A., Sanchez, R. M., Merlos, M. et al., Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-κB activation. Endocrinology 2006, 147, 552-561.
16. Weigert, C., Brodbeck, K., Staiger, H., Kausch, C. et al., Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB. J. Biol. Chem. 2004, 279, 23942-23952.
17. Hommelberg, P. P., Langen, R. C., Schols, A. M., van Essen, A. L. et al., Trans fatty acid-induced NF-kappaB activation does not induce insulin resistance in cultured murine skeletal muscle cells. Lipids 2010, 45, 285-290.
18. McGuire, M. A., McGuire, M. K., Conjugated linoleic acid (CLA): A ruminant fatty acid with beneficial effects on human health. J. Anim. Sci. 2000, 77, 1-8.
19. Silveira, M. B., Carraro, R., Monereo, S., Tebar, J., Conjugated linoleic acid (CLA) and obesity. Public Health Nutr. 2007, 10, 1181-1186.
20. Langen, R. C., Schols, A. M., Kelders, M. C., Wouters, E. F., Janssen-Heininger, Y. M., Enhanced myogenic differentiation by extracellular matrix Is regulated at the early stages of myogenesis. In Vitro Cell Dev. Biol. Anim. 2003, 39, 163-169.
21. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B. et al., Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3, RESEARCH0034.
22. Larsen, A. E., Cameron-Smith, D., Crowe, T. C., Conjugated linoleic acid suppresses myogenic gene expression in a model of human muscle cell inflammation. J. Nutr. 2008, 138, 12-16.
23. Hurley, M. S., Flux, C., Salter, A. M., Brameld, J. M., Effects of fatty acids on skeletal muscle cell differentiation in vitro. Br. J. Nutr. 2006, 95, 623-630.
24. Allen, R. E., Dodson, M. V., Luiten, L. S., Boxhorn, L. K., A serum-free medium that supports the growth of cultured skeletal muscle satellite cells. In Vitro Cell Dev. Biol. 1985, 21, 636-640.
25. Allen, R. E., Luiten, L. S., Dodson, M. V., Effect of insulin and linoleic acid on satellite cell differentiation. J. Anim. Sci. 1985, 60, 1571-1579.
26. Cui, Z., Chen, X., Lu, B., Park, S. K. et al., Preliminary quantitative profile of differential protein expression between rat L6 myoblasts and myotubes by stable isotope labeling with amino acids in cell culture. Proteomics 2009, 9, 1274-1292.
27. Tannu, N. S., Rao, V. K., Chaudhary, R. M., Giorgianni, F. et al., Comparative proteomes of the proliferating C(2)C(12) myoblasts and fully differentiated myotubes reveal the complexity of the skeletal muscle differentiation program. Mol. Cell. Proteomics 2004, 3, 1065-1082.
28. Chavez, J. A., Summers, S. A., Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch. Biochem. Biophys. 2003, 419, 101-109.
29. Senn, J. J., Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J. Biol. Chem. 2006, 281, 26865-26875.
30. Frost, R. A., Nystrom, G. J., Lang, C. H., Lipopolysaccharide stimulates nitric oxide synthase-2 expression in murine skeletal muscle and C(2)C(12) myoblasts via Toll-like receptor-4 and c-Jun NH(2)-terminal kinase pathways. Am. J. Physiol. Cell Physiol. 2004, 287, C1605-1615.
31. Frost, R. A., Nystrom, G. J., Lang, C. H., Multiple Toll-like receptor ligands induce an IL-6 transcriptional response in skeletal myocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290, R773-R784.
32. Satory, D. L., Smith, S. B., Conjugated linoleic acid inhibits proliferation but stimulates lipid filling of murine 3T3-L1 preadipocytes. J. Nutr. 1999, 129, 92-97.
33. Brodie, A. E., Manning, V. A., Ferguson, K. R., Jewell, D. E., Hu, C. Y., Conjugated linoleic acid inhibits differentiation of pre- and post- confluent 3T3-L1 preadipocytes but inhibits cell proliferation only in preconfluent cells. J. Nutr. 1999, 129, 602-606.
34. Brown, J. M., Boysen, M. S., Jensen, S. S., Morrison, R. F. et al., Isomer-specific regulation of metabolism and PPARgamma signaling by CLA in human preadipocytes. J. Lipid Res. 2003, 44, 1287-1300.
35. Kennedy, A., Chung, S., LaPoint, K., Fabiyi, O., McIntosh, M. K., Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes. J. Nutr. 2008, 138, 455-461.
36. Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G. et al., PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 1999, 4, 611-617.
37. Singh, J., Verma, N. K., Kansagra, S. M., Kate, B. N., Dey, C. S., Altered PPARgamma expression inhibits myogenic differentiation in C2C12 skeletal muscle cells. Mol. Cell. Biochem. 2007, 294, 163-171.
38. Houseknecht, K. L., Vanden Heuvel, J. P., Moya-Camarena, S. Y., Portocarrero, C. P. et al., Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem. Biophys. Res. Commun. 1998, 244, 678-682.
39. Ryder, J. W., Portocarrero, C. P., Song, X. M., Cui, L. et al., Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 2001, 50, 1149-1157.
40. Henriksen, E. J., Teachey, M. K., Taylor, Z. C., Jacob, S. et al., Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat. Am. J. Physiol. Endocrinol. Metab. 2003, 285, E98-E105.
41. Tsuboyama-Kasaoka, N., Takahashi, M., Tanemura, K., Kim, H. J. et al., Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 2000, 49, 1534-1542.
42. Clement, L., Poirier, H., Niot, I., Bocher, V. et al., Dietary trans-10, cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J. Lipid Res. 2002, 43, 1400-1409.
43. Kelley, D. S., Vemuri, M., Adkins, Y., Gill, S. H. et al., Flaxseed oil prevents trans-10, cis-12-conjugated linoleic acid-induced insulin resistance in mice. Br. J. Nutr. 2008, 101, 701-708.
44. Vemuri, M., Kelley, D. S., Mackey, B. E., Rasooly, R., Bartolini, G., Docosahexaenoic acid (DHA) but not ecosapentaenoic acid (EPA) prevents trans-10, cis-12 conjugated linoleic acid (CLA)-induced insulin resistance in mice. Metab. Syndr. Relat. Disord. 2007, 5, 315-322.
45. Raff, M., Tholstrup, T., Basu, S., Nonboe, P. et al., A diet rich in conjugated linoleic acid and butter increases lipid peroxidation but does not affect atherosclerotic, inflammatory, or diabetic risk markers in healthy young men. J. Nutr. 2008, 138, 509-514.
46. Riserus, U., Arner, P., Brismar, K., Vessby, B., Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002, 25, 1516-1521.
47. Riserus, U., Vessby, B., Arnlov, J., Basu, S., Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am. J. Clin. Nutr. 2004, 80, 279-283.
48. Riserus, U., Basu, S., Jovinge, S., Fredrikson, G. N. et al., Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 2002, 106, 1925-1929.
49. Purushotham, A., Wendel, A. A., Liu, L. F., Belury, M. A., Maintenance of adiponectin attenuates insulin resistance induced by dietary conjugated linoleic acid in mice. J. Lipid Res. 2007, 48, 444-452.
50. Park, Y., Storkson, J. M., Albright, K. J., Liu, W., Pariza, M. W., Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999, 34, 235-241.
51. Hargrave, K. M., Li, C., Meyer, B. J., Kachman, S. D. et al., Adipose depletion and apoptosis induced by trans-10, cis-12 conjugated linoleic acid in mice. Obes. Res. 2002, 10, 1284-1290.
52. Belury, M. A., Mahon, A., Banni, S., The conjugated linoleic acid (CLA) isomer, t10c12-CLA, is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus. J. Nutr. 2003, 133, 257S-260S.
53. Degrace, P., Demizieux, L., Gresti, J., Chardigny, J. M. et al., Hepatic steatosis is not due to impaired fatty acid oxidation capacities in C57BL/6J mice fed the conjugated trans-10, cis-12-isomer of linoleic acid. J. Nutr. 2004, 134, 861-867.
54. Degrace, P., Demizieux, L., Gresti, J., Chardigny, J. M. et al., Association of liver steatosis with lipid oversecretion and hypotriglyceridaemia in C57BL/6j mice fed trans-10, cis-12-linoleic acid. FEBS Lett. 2003, 546, 335-339.
55. Kelley, D. S., Vemuri, M., Adkins, Y., Gill, S. H. et al., Flaxseed oil prevents trans-10, cis-12-conjugated linoleic acid-induced insulin resistance in mice. Br. J. Nutr. 2009, 101, 701-708.
56. Chung, S., Brown, J. M., Provo, J. N., Hopkins, R., McIntosh, M. K., Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. J. Biol. Chem. 2005, 280, 38445-38456.
57. Kennedy, A., Overman, A., Lapoint, K., Hopkins, R. et al., Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol. J. Lipid Res. 2009, 50, 225-232.
58. Zulet, M. A., Marti, A., Parra, M. D., Martinez, J. A., Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health. J. Physiol. Biochem. 2005, 61, 483-494.